NCT05447442 Guideline Adherence for Preoperative Anemia Management in a PAC
| NCT ID | NCT05447442 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Siriraj Hospital |
| Condition | Guideline Adherence |
| Study Type | OBSERVATIONAL |
| Enrollment | 93 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 93 participants in total. It began in 2022-10-01 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anemia in surgical patients is a common seriously problem; around 40 % of patients presenting for major surgery are anemic problem. Patients with major surgery have significantly higher rates of acute blood loss. Whereas , patients with pre-operative anemia prone to be transfused blood component in pre-operative or intraoperative and postoperative periods that associated with worse outcomes , prolonged hospital stays , increased risk of morbidity and mortality . Therefore, patients undergoing major surgery should be optimization for pre-operative anemia. In November 2021, Siriraj Preanesthesia Assessment Center (SIPAC) has developed and implemented a preoperative anemia management guideline which is one pillar of perioperative patient blood management. The objective of this guideline is to optimize red blood cell mass before patients having operation. The investigators are realize the important of pre-operative anemia of patients who undergoing elective surgery. The investigators will aim to evaluate adherence to the preoperative anemia management guideline protocol and perioperative outcomes and use the data of this study to setting guidelines for preoperative anemia evaluation and management in SIPAC of department of anesthesiology in Siriraj hospital for improving workflow and optimization before elective surgery, supporting to a reduction in blood transfusion, hospital stay, morbidity and health care costs of public health of Thailand.
Eligibility Criteria
Inclusion Criteria Patients who attend a preanesthesia clinic and have anemia. Anemia defined as 1. Patients, with chronic kidney disease (CKD) stage 3+ or hematologic disease, have a hemoglobin level less than 10 g/dL; or 2. Patients other than No. 1 and have hemoglobin level less than 13 g/dL in men or a hemoglobin level less than 12 g/dL in women. Exclusion Criteria: * none
Contact & Investigator
Mingkwan Wongyingsinn
PRINCIPAL INVESTIGATOR
Siriraj Hospital
Frequently Asked Questions
Who can join the NCT05447442 clinical trial?
This trial is open to participants of all sexes, studying Guideline Adherence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05447442 currently recruiting?
Yes, NCT05447442 is actively recruiting participants. Contact the research team at mingkwan.won@mahidol.ac.th for enrollment information.
Where is the NCT05447442 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT05447442 clinical trial?
NCT05447442 is sponsored by Siriraj Hospital. The principal investigator is Mingkwan Wongyingsinn at Siriraj Hospital. The trial plans to enroll 93 participants.